ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 859 • 2013 ACR/ARHP Annual Meeting

    Knee Effusion: Sensitivity and Specificity Of Ultrasound For The Identification Of Calcium Pyrophosphate Crystals

    Erika Catay1, Santiago Ruta2, Javier Rosa1, David A. Navarta3, Marina Scolnik4, Ricardo Garcia-Monaco5 and Enrique R. Soriano6, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 3Internal Medicine, Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 5Radiology and Imagenology Department, Hospital italiano de Buenos Aires, Buenos Aires, Argentina, 6Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina

    Background/Purpose:  Calcium pyrophosphate deposition disease (CPPD) is an important cause of arthritis mainly in elderly people. The final diagnosis is based on the identification of…
  • Abstract Number: 861 • 2013 ACR/ARHP Annual Meeting

    Many Gout Patients Treated By Rheumatologists Do Not Meet Established Treatment Goals Despite Long-Term Urate Lowering Therapy: Results Of a Gout Patient Encounter Survey

    Max I. Hamburger1, Michael H. Pillinger2, Robert Sederman3 and Gary Fernandez4, 1Rheumatology Associates, Melville, NY, 2NYU School of Medicine, Division of Rheumatology, New York, NY, 3C1 Consulting, LLC, Summit, NJ, 4Market Research, Savient Pharmaceuticals, Bridgewater, NJ

    Background/Purpose: In Oct 2012, the ACR published guidelines for the management of gout. These guidelines recommend pharmacologic treatment that results in a sufficient lowering of…
  • Abstract Number: 862 • 2013 ACR/ARHP Annual Meeting

    Ten-Year Incidence of Self-Reported Nonvertebral Fractures in 9,720 Japanese Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study

    Kensuke Ochi1, Takefumi Furuya1, Eisuke Inoue2, Katsunori Ikari1, Atsuo Taniguchi2, Hisashi Yamanaka1 and Shigeki Momohara2, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Ten-Year Incidence of Self-reported Nonvertebral Fractures in 9,720 Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study Background/Purpose: Although rheumatoid arthritis (RA) is a…
  • Abstract Number: 863 • 2013 ACR/ARHP Annual Meeting

    Romosozumab Administration Is Associated With Significant Improvements In Lumbar Spine and Hip Volumetric Bone Mineral Density and Content Compared With Teriparatide

    H K Genant1, S Boonen2, M A Bolognese3, C Mautalen4, J P Brown5, C Recknor6, S Goemaere7, K Engelke8, Y-C Yang9, M Austin9, A Grauer9 and C Libanati9, 1UCSF & Synarc Inc., San Francisco, CA, 2Leuven University Division of Geriatric Medicine, Leuven, Belgium, 3The Bethesda Health Research Center, Bethesda, MD, 4Centro de Osteopatias Medicas, Buenos Aires, Argentina, 5CHU de Québec Research Centre and Laval University, Québec, QC, Canada, 6United Osteoporosis Centers, Gainesville, GA, 7Ghent University Hospital, Ghent, Belgium, 8Synarc Germany, Hamburg, Germany, 9Amgen Inc., Thousand Oaks, CA

    Background/Purpose: Sclerostin is an osteocyte-derived inhibitor of osteoblast activity. Romosozumab, a monoclonal antibody to sclerostin stimulates bone formation and decreases bone resorption. In a phase…
  • Abstract Number: 864 • 2013 ACR/ARHP Annual Meeting

    Further Reduction In Nonvertebral Fracture Rate Is Observed Following 3 Years Of Denosumab Treatment: Results With Up To 7 Years In The Freedom Extension

    Jonathan D. Adachi1, Serge Ferrari2, Carol Zapalowski3, Paul D. Miller4, Jean-Yves Reginster5, Ove Törring6, Nadia Daizadeh3, Andrea Wang3, Cynthia O'Malley7, Rachel B. Wagman3 and E. Michael Lewiecki8, 1McMaster University, Hamilton, ON, Canada, 2Geneva University Hospital, Geneva, Switzerland, 3Amgen Inc., Thousand Oaks, CA, 4Colorado Center for Bone Research, Lakewood, CO, 5University of Liège, Liège, Belgium, 6Karolinska Institutet, Södersjukhuset, Stockholm, Sweden, 7Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, 8New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM

    Further Reduction in Nonvertebral Fracture Rate Is Observed Following 3 Years of Denosumab Treatment: Results With up to 7 Years in the FREEDOM ExtensionBackground/Purpose: Some…
  • Abstract Number: 865 • 2013 ACR/ARHP Annual Meeting

    Vertebral Fractures In The 3 Year Period Following Steroid Initiation Among Children With Chronic Illnesses

    Johannes Roth1, Jinhui Ma1, David A. Cabral2, Peter B. Dent3, Janet E. Ellsworth4, Adam M. Huber5, Kristin M. Houghton2, Roman Jurencak1, Bianca A. Lang5, Maggie Larche3, Claire MA Leblanc6, Brian Lentle2, MaryAnn Matzinger1, Paivi M. Miettunen7, Kiem Oen8, Claire Saint-cyr9, Rosie Scuccimarri10, Nazih Shenouda1, Leanne M. Ward1 and The Canadian STOPP Consortium11, 1University of Ottawa, Ottawa, ON, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3McMaster University, Hamilton, ON, Canada, 4University of Alberta, Edmonton, AB, Canada, 5Dalhousie University, Halifax, NS, Canada, 6McGill University, Montréal, QC, Canada, 7University of Calgary, Calgary, AB, Canada, 8University of Manitoba, Winnipeg, MB, Canada, 9Université de Montréal, Montreal, QC, Canada, 10McGill University, Montreal, QC, Canada, 11National Pediatric Bone Health Working Group, Ottawa, ON, Canada

    Background/Purpose: :   To describe the pattern and frequency of incident vertebral fractures (VF) in glucocorticoid (GC)-treated children and to determine the clinical factors at baseline…
  • Abstract Number: 866 • 2013 ACR/ARHP Annual Meeting

    Use Of Non Steroidal Anti-Inflammatory Drugs Prevent Bone Loss In Patients With Early Inflammatory Back Pain:  Results From The DESIR Cohort

    Karine Briot1, Simon Paternotte2, Corinne Miceli-Richard3, Maxime Dougados2,4 and Christian Roux1, 1Cochin hospital, Paris Descartes University, Paris, France, 2Cochin Hospital, Paris Descartes University, Paris, France, 3Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France, 4Université Paris René Descartes and Hôpital Cochin, Paris, France

    Background/Purpose: To assess the 2-year bone mineral density (BMD) changes at lumbar spine and hip in a large cohort of patients with early inflammatory back…
  • Abstract Number: 867 • 2013 ACR/ARHP Annual Meeting

    Reduced Hip Cortical Porosity Upon Denosumab Treatment: A Likely Mechanism Contributing To The Reduction Of Hip Fracture Risk In Women With Osteoporosis

    R. M. Zebaze1, C. Libanati2, M. R. McClung3, J. R. Zanchetta4, D. L. Kendler5, A. Høiseth6, A. Wang2, A. Ghasem-Zadeh1 and E. Seeman1, 1Austin Health, University of Melbourne, Melbourne, Australia, 2Amgen Inc., Thousand Oaks, CA, 3Oregon Osteoporosis Center, Portland, OR, 4Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina, 5University of British Columbia, Vancouver, BC, Canada, 6Curato Røntgen, Oslo, Norway

    Background/Purpose: Nonvertebral fracture risk is significantly influenced by cortical thickness, area, mass, and porosity because all of these contribute to bone strength. In particular, increased…
  • Abstract Number: 834 • 2013 ACR/ARHP Annual Meeting

    Physical Activity Behavior In Patients With Arthritis

    Gustavo J. Almeida1 and Sara R. Piva2, 1Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 2Physical Therapy, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: : The physical activity (PA) guidelines issued by the US Health and Human Services (HHS) recommend that adults with arthritis should perform at least…
  • Abstract Number: 843 • 2013 ACR/ARHP Annual Meeting

    Endogenous Pain Modulation In The Ehlers-Danlos Syndrome, Hypermobility Type

    Inge De Wandele, Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, Belgium

    Background/Purpose: The Ehlers-Danlos Syndrome (EDS) is the most prevalent heritable connective tissue disorder. More than 90% of individuals are classified as having the hypermobility type…
  • Abstract Number: 828 • 2013 ACR/ARHP Annual Meeting

    Psychosocial Determinants Of Total Knee Arthroplasty Outcomes 2 Years After Surgery

    Aparna Ingleshwar1, Maria A. Lopez-Olivo2, Glenn C. Landon3, Sherwin J. Siff3, Andrea Barbo4 and Maria E. Suarez-Almazor5, 1General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 2General Internal Medicine, University of Texas. M.D Anderson Cancer Center, Houston, TX, 3St. Luke's Episcopal Health System, Houston, TX, 4Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, 5The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: To explore potential psychosocial and demographic factors that influence Total Knee Arthroplasty (TKA) outcomes and satisfaction at 24 months. Methods: A prospective cohort study…
  • Abstract Number: 829 • 2013 ACR/ARHP Annual Meeting

    Is The Severity Of Knee Osteoarthritis On MRI Associated With Outcome Of Exercise Therapy?

    Jesper Knoop1, Joost Dekker2, Marike van der Leeden3,4, Martin van der Esch4, J.P. Klein5, David J. Hunter6, Leo D. Roorda4, Martijn P.M. Steultjens7 and Willem F. Lems8, 1Amsterdam Rehabilitation Research Center, Reade, centre for rehabilitation and rheumatology, Amsterdam, Netherlands, 2Rehabilitation Medicine, Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, 3Rehabilitation Medicine/EMGO, VU University Medical Center, Amsterdam, Netherlands, 4Amsterdam Rehabilitation Research Center | Reade, Amsterdam, the Netherlands, Amsterdam, Netherlands, 5Radiology, VU University Medical Center, Amsterdam, Netherlands, 6Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 7Institute for Applied Health Research and School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, 8Rheumatology, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: To evaluate associations between severity of knee osteoarthritis (OA) on MRI and treatment outcome in knee OA patients treated with exercise therapy. Methods: Ninety-five…
  • Abstract Number: 830 • 2013 ACR/ARHP Annual Meeting

    Ethnic Variations At Time Of Surgery and During Follow-Up In Patients Undergoing Total Knee Arthroplasty

    Aparna Ingleshwar1, Andrea Barbo2, Glenn C. Landon3, Sherwin J. Siff3, Sofia De Achaval4 and Maria E. Suarez-Almazor5, 1General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 2Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, 3St. Luke's Episcopal Health System, Houston, TX, 4General Internal Medicine, U.T. MD Anderson Cancer Center, Houston, TX, 5The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Literature reports sizable improvements in pain and function in patients having undergone Total Knee Arthroplasty (TKA) procedure. However, significant disparities exist in the utilization…
  • Abstract Number: 831 • 2013 ACR/ARHP Annual Meeting

    Relationships Between Clinical Outcome Measures and Gait Variables Before and After Total Hip Arthroplasty

    Kharma C. Foucher1,2 and Omar Behery3, 1Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, 2Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Inadequate clinical response in a substantial portion of total hip arthroplasty (THA) patients, 1 as well as gait deficits after THA 2 have been…
  • Abstract Number: 832 • 2013 ACR/ARHP Annual Meeting

    Factors That Affect Tender and Swollen Joint Counts In Rheumatoid Arthritis

    Christine L. Amity1, Marisa Eckels2, Kenneth N. Gold3, Kelly A. Reckley4, Niveditha Mohan5, Stephen R. Wisniewski6, Elizabeth A. Schlenk7, Marc C. Levesque8,9 and Terence W. Starz10, 1Rheumatology & Clinical Immun, Univ of Pittsburgh, Pittsburgh, PA, 2Arthritis and Internal Medicine Associates, University of Pittsburgh Medical Center, Pittsburgh, PA, 3Arthritis & Internal Medicine, Pittsburgh, PA, 4Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 5Div of Rheum & Clin Immunol, Univ of Pittsburgh Arth Inst, Pittsburgh, PA, 6Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 7School of Nursing, University of Pittsburgh, Pittsburgh, PA, 8Division of Rheumatology and Clinical Immunology, University of Pittsburgh Department of Medicine, Pittsburgh, PA, 9Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 10Arth & Internal Med Associates, Pittsburgh, PA

    Background/Purpose: Quantitative joint counts are used to determine rheumatoid arthritis (RA) disease activity and are increasingly important for routine clinical practice to optimize patient care.…
  • « Previous Page
  • 1
  • …
  • 2191
  • 2192
  • 2193
  • 2194
  • 2195
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology